Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
Biochemistry|June 23, 2009
Reaction kinetics, catalytic mechanisms, conformational changes, and inhibitor design for prenyltransferasesPo-Huang LiangCurrent Topics in Medicinal Chemistry|April 14, 2006
Characterization and inhibition of SARS-coronavirus main proteasePo-Huang LiangProtein Science : a Publication of the Protein Society|November 2, 2023
Complexation and evolution of cis-prenyltransferase homologues in Cinnamomum kanehirae deduced from kinetic and functional characterizationsJia-Jin Liu, Po-Huang LiangMolecular Membrane Biology|April 5, 2012
Undecaprenyl diphosphate synthase, a cis-prenyltransferase synthesizing lipid carrier for bacterial cell wall biosynthesisKuo-Hsun Teng, Po-Huang LiangFEBS Letters|March 18, 2022
SARS-CoV-2 3CL<sup>pro</sup> displays faster self-maturation in vitro than SARS-CoV 3CL<sup>pro</sup> due to faster C-terminal cleavageChih-Jung Kuo, Po-Huang LiangExpert Opinion on Therapeutic Patents|December 22, 2009
Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitorsHui-Min Wang, Po-Huang LiangBiochimica Et Biophysica Acta|December 14, 2002
Reaction kinetic pathway of the recombinant octaprenyl pyrophosphate synthase from Thermotoga maritima: how is it different from that of the mesophilic enzymeTun-Hsun Kuo, Po-Huang LiangBioorganic Chemistry|October 14, 2011
Structures, mechanisms and inhibitors of undecaprenyl diphosphate synthase: a cis-prenyltransferase for bacterial peptidoglycan biosynthesisKuo-Hsun Teng, Po-Huang LiangExpert Opinion on Therapeutic Patents|August 3, 2013
Anti-SARS coronavirus agents: a patent review (2008 - present)Vathan Kumar, Young-Sik Jung, Po-Huang LiangBiochemical Society Transactions|September 23, 2011
Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discoveryR Ramajayam, Kian-Pin Tan, Po-Huang LiangPageof 11